CN
菜单
    About us
    ETERN was established in 2018, focusing on the
    research and development of small molecule
    drugs targeting protein liquid-liquid
    phase separation
    More about us
    ETERN is committed to developing Liquid-Liquid Phase Separation Platform to target "undruggable" proteins
    Contact us
    If you would like to learn more about ETERN, please mail to: contact@eternbio.com